Video
Author(s):
“We need to treat our patients with stones, both medically and surgically,” says Glenn M. Preminger, MD.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
In this video, Glenn M. Preminger, MD, reflects on advancements in stone treatment at his own practice and predicts further research in this field. Preminger is a urologist and professor of surgery at Duke University Medical Center, Durham, North Carolina.
Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
FDA Advisory Committee unanimously votes against talazoparib plus enzalutamide for mCRPC
FDA Advisory Committee finds evidence for UGN-102 inconclusive, cites uncertainty in benefit-risk
Pivotal trial launches of 64Cu-SAR-bisPSMA in BCR of prostate cancer
2 Commerce Drive
Cranbury, NJ 08512